SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1pkq'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_F_CLMF1144_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY B 53 PRO B 52 THR B 57 ILE B 51 GLY B 55	None	1.41A	1usqF-1pkqB: undetectable	1usqF-1pkqB: 19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2FQY_A_ADNA400_1 (MEMBRANE LIPOPROTEIN TMPC)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	ASP B 86 PHE B 63 MET B 80 PHE B 69 GLY B 65	None	1.25A	2fqyA-1pkqB: undetectable	2fqyA-1pkqB: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_E_CLME1141_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY B 53 PRO B 52 THR B 57 ILE B 51 GLY B 55	None	1.40A	2jkjE-1pkqB: undetectable	2jkjE-1pkqB: 19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_E_CLME1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY B 53 PRO B 52 THR B 57 ILE B 51 GLY B 55	None	1.41A	2jklE-1pkqB: undetectable	2jklE-1pkqB: 19.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA302_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	4 / 6	LEU B 189 GLY B 190 ALA B 125 PRO B 126	None	0.50A	3huoA-1pkqB: undetectable	3huoA-1pkqB: 22.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4COX_C_IMNC701_1 (CYCLOOXYGENASE-2)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	LEU B 82 SER B 17 VAL B 12 GLY B 10 ALA B 9	None	1.10A	4coxC-1pkqB: undetectable	4coxC-1pkqB: 18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4JX1_B_CAMB502_0 (CAMPHOR 5-MONOOXYGENASE)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 10	PHE B 122 GLY B 118 THR B 205 VAL B 198 VAL B 207	None	1.20A	4jx1B-1pkqB: undetectable	4jx1B-1pkqB: 20.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.89A	4qvnH-1pkqB: undetectable 4qvnI-1pkqB: undetectable	4qvnH-1pkqB: 20.74 4qvnI-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 10	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.89A	4qvnV-1pkqB: undetectable 4qvnW-1pkqB: 0.2	4qvnV-1pkqB: 20.74 4qvnW-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.86A	4qvpH-1pkqB: undetectable 4qvpI-1pkqB: undetectable	4qvpH-1pkqB: 20.74 4qvpI-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.86A	4qvpV-1pkqB: undetectable 4qvpW-1pkqB: undetectable	4qvpV-1pkqB: 20.74 4qvpW-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.88A	4qvqH-1pkqB: undetectable 4qvqI-1pkqB: undetectable	4qvqH-1pkqB: 20.74 4qvqI-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.88A	4qvqV-1pkqB: undetectable 4qvqW-1pkqB: undetectable	4qvqV-1pkqB: 20.74 4qvqW-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.93A	4qvvH-1pkqB: undetectable	4qvvH-1pkqB: 20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.92A	4qvvV-1pkqB: undetectable	4qvvV-1pkqB: 20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.93A	4qvyH-1pkqB: undetectable	4qvyH-1pkqB: 20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.93A	4qvyV-1pkqB: undetectable 4qvyW-1pkqB: undetectable	4qvyV-1pkqB: 20.74 4qvyW-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.91A	4qw0H-1pkqB: undetectable 4qw0I-1pkqB: undetectable	4qw0H-1pkqB: 20.74 4qw0I-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.91A	4qw0V-1pkqB: undetectable 4qw0W-1pkqB: undetectable	4qw0V-1pkqB: 20.74 4qw0W-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.90A	4qw1H-1pkqB: undetectable 4qw1I-1pkqB: undetectable	4qw1H-1pkqB: 20.74 4qw1I-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.89A	4qw1V-1pkqB: undetectable 4qw1W-1pkqB: undetectable	4qw1V-1pkqB: 20.74 4qw1W-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.90A	4qwuH-1pkqB: undetectable 4qwuI-1pkqB: 0.5	4qwuH-1pkqB: 20.74 4qwuI-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.90A	4qwuV-1pkqB: undetectable 4qwuW-1pkqB: undetectable	4qwuV-1pkqB: 20.74 4qwuW-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.91A	5cz7V-1pkqB: undetectable 5cz7W-1pkqB: undetectable	5cz7V-1pkqB: 20.74 5cz7W-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.91A	5d0xV-1pkqB: undetectable	5d0xV-1pkqB: 20.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.88A	5l5fH-1pkqB: undetectable 5l5fI-1pkqB: undetectable	5l5fH-1pkqB: 20.74 5l5fI-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.88A	5l5fV-1pkqB: undetectable 5l5fW-1pkqB: undetectable	5l5fV-1pkqB: 20.74 5l5fW-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.88A	5l66H-1pkqB: undetectable 5l66I-1pkqB: undetectable	5l66H-1pkqB: 20.74 5l66I-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L66_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER B 188 GLY B 134 THR B 135 ALA B 136 THR B 131	None	0.88A	5l66V-1pkqB: undetectable 5l66W-1pkqB: undetectable	5l66V-1pkqB: 20.74 5l66W-1pkqB: 24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6EQP_A_BUWA601_1 (CHOLINESTERASE)	1pkq	(8-18C5) CHIMERIC FAB, HEAVY CHAIN (Mus musculus)	4 / 8	GLY B 10 THR B 108 PHE B 146 TYR B 176	None	0.94A	6eqpA-1pkqB: undetectable	6eqpA-1pkqB: 15.48

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1USQ_F_CLMF1144_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"GLY B  53;PRO B  52;THR B  57;ILE B  51;GLY B  55","None","1.41A","1usqF-1pkqB:undetectable","1usqF-1pkqB:19.69"],["2FQY_A_ADNA400_1","MEMBRANE LIPOPROTEIN TMPC","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"ASP B  86;PHE B  63;MET B  80;PHE B  69;GLY B  65","None","1.25A","2fqyA-1pkqB:undetectable","2fqyA-1pkqB:20.63"],["2JKJ_E_CLME1141_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"GLY B  53;PRO B  52;THR B  57;ILE B  51;GLY B  55","None","1.40A","2jkjE-1pkqB:undetectable","2jkjE-1pkqB:19.69"],["2JKL_E_CLME1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"GLY B  53;PRO B  52;THR B  57;ILE B  51;GLY B  55","None","1.41A","2jklE-1pkqB:undetectable","2jklE-1pkqB:19.69"],["3HUO_A_PNNA302_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",4,"LEU B 189;GLY B 190;ALA B 125;PRO B 126","None","0.50A","3huoA-1pkqB:undetectable","3huoA-1pkqB:22.33"],["4COX_C_IMNC701_1","CYCLOOXYGENASE-2","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"LEU B  82;SER B  17;VAL B  12;GLY B  10;ALA B   9","None","1.10A","4coxC-1pkqB:undetectable","4coxC-1pkqB:18.58"],["4JX1_B_CAMB502_0","CAMPHOR 5-MONOOXYGENASE","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"PHE B 122;GLY B 118;THR B 205;VAL B 198;VAL B 207","None","1.20A","4jx1B-1pkqB:undetectable","4jx1B-1pkqB:20.90"],["4QVN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.89A","4qvnH-1pkqB:undetectable;4qvnI-1pkqB:undetectable","4qvnH-1pkqB:20.74;4qvnI-1pkqB:24.05"],["4QVN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.89A","4qvnV-1pkqB:undetectable;4qvnW-1pkqB:0.2","4qvnV-1pkqB:20.74;4qvnW-1pkqB:24.05"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.86A","4qvpH-1pkqB:undetectable;4qvpI-1pkqB:undetectable","4qvpH-1pkqB:20.74;4qvpI-1pkqB:24.05"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.86A","4qvpV-1pkqB:undetectable;4qvpW-1pkqB:undetectable","4qvpV-1pkqB:20.74;4qvpW-1pkqB:24.05"],["4QVQ_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.88A","4qvqH-1pkqB:undetectable;4qvqI-1pkqB:undetectable","4qvqH-1pkqB:20.74;4qvqI-1pkqB:24.05"],["4QVQ_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.88A","4qvqV-1pkqB:undetectable;4qvqW-1pkqB:undetectable","4qvqV-1pkqB:20.74;4qvqW-1pkqB:24.05"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.93A","4qvvH-1pkqB:undetectable","4qvvH-1pkqB:20.74"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.92A","4qvvV-1pkqB:undetectable","4qvvV-1pkqB:20.74"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.93A","4qvyH-1pkqB:undetectable","4qvyH-1pkqB:20.74"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.93A","4qvyV-1pkqB:undetectable;4qvyW-1pkqB:undetectable","4qvyV-1pkqB:20.74;4qvyW-1pkqB:24.05"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.91A","4qw0H-1pkqB:undetectable;4qw0I-1pkqB:undetectable","4qw0H-1pkqB:20.74;4qw0I-1pkqB:24.05"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.91A","4qw0V-1pkqB:undetectable;4qw0W-1pkqB:undetectable","4qw0V-1pkqB:20.74;4qw0W-1pkqB:24.05"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.90A","4qw1H-1pkqB:undetectable;4qw1I-1pkqB:undetectable","4qw1H-1pkqB:20.74;4qw1I-1pkqB:24.05"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.89A","4qw1V-1pkqB:undetectable;4qw1W-1pkqB:undetectable","4qw1V-1pkqB:20.74;4qw1W-1pkqB:24.05"],["4QWU_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.90A","4qwuH-1pkqB:undetectable;4qwuI-1pkqB:0.5","4qwuH-1pkqB:20.74;4qwuI-1pkqB:24.05"],["4QWU_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.90A","4qwuV-1pkqB:undetectable;4qwuW-1pkqB:undetectable","4qwuV-1pkqB:20.74;4qwuW-1pkqB:24.05"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.91A","5cz7V-1pkqB:undetectable;5cz7W-1pkqB:undetectable","5cz7V-1pkqB:20.74;5cz7W-1pkqB:24.05"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.91A","5d0xV-1pkqB:undetectable","5d0xV-1pkqB:20.74"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.88A","5l5fH-1pkqB:undetectable;5l5fI-1pkqB:undetectable","5l5fH-1pkqB:20.74;5l5fI-1pkqB:24.05"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.88A","5l5fV-1pkqB:undetectable;5l5fW-1pkqB:undetectable","5l5fV-1pkqB:20.74;5l5fW-1pkqB:24.05"],["5L66_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.88A","5l66H-1pkqB:undetectable;5l66I-1pkqB:undetectable","5l66H-1pkqB:20.74;5l66I-1pkqB:24.05"],["5L66_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",5,"SER B 188;GLY B 134;THR B 135;ALA B 136;THR B 131","None","0.88A","5l66V-1pkqB:undetectable;5l66W-1pkqB:undetectable","5l66V-1pkqB:20.74;5l66W-1pkqB:24.05"],["6EQP_A_BUWA601_1","CHOLINESTERASE","1pkq","(8-18C5) CHIMERIC FAB, HEAVY CHAIN","Mus musculus",4,"GLY B  10;THR B 108;PHE B 146;TYR B 176","None","0.94A","6eqpA-1pkqB:undetectable","6eqpA-1pkqB:15.48"]]